MedPath

Phenytoin or levetiracetam for seizure control in children with nervous system infection.

Not Applicable
Conditions
Health Condition 1: G049- Encephalitis, myelitis and encephalomyelitis, unspecified
Registration Number
CTRI/2021/03/031897
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Children with Acute Encephalitis Syndrome with

2.History of Acute symptomatic seizures/seizure occurrence after hospitalization/other indication for anti-epileptic drug administration.

3.Parents giving informed consent.

Exclusion Criteria

1.Children with past history of seizures, previous occurrence of focal neurological deficit, or abnormal developmental history before the seizure episode.

2.Children with HIV, Chronic Liver disease, Chronic Kidney disease, acute hepatic encephalopathy.

3. Received any anti-epileptic drug previously.

4. Any specific contraindication/allergy for Phenytoin/ Levetiracetam.

5. Refusal to consent by the caregiver.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath